Many Bright Ideas Technologies (TSXV:MBI.H) Short Interest

View and export this data going back to 2002. Start your Free Trial

What is Many Bright Ideas Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Many Bright Ideas Technologies's Short Interest

For the Diagnostics & Research subindustry, Many Bright Ideas Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Many Bright Ideas Technologies's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Many Bright Ideas Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where Many Bright Ideas Technologies's Short Interest falls into.

Many Bright Ideas Technologies (TSXV:MBI.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Many Bright Ideas Technologies Inc (TSXV:MBI.H) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

MBGNF:USA

Address

598 East Kent Avenue South, Vancouver, BC, CAN, V5X 4V6

Website

http://www.medbiogene.com

Many Bright Ideas Technologies Inc is a Canada-based life science company. It focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with early-stage non-small-cell lung cancer.

Many Bright Ideas Technologies (TSXV:MBI.H) Headlines

No Headlines